Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,991 | -21,785 | -10,902 | -1,571 | -19,449 |
| Depreciation Amortization | 684 | 582 | 410 | 294 | 51 |
| Accounts receivable | 2,302 | -4,001 | 3,153 | -1,556 | N/A |
| Accounts payable and accrued liabilities | 3,155 | 578 | -1,537 | 2,536 | -248 |
| Other Working Capital | 15,982 | -1,156 | 7,364 | -2,134 | -1,115 |
| Other Operating Activity | -2,577 | 5,022 | 1,052 | -430 | 2,613 |
| Operating Cash Flow | $-6,445 | $-20,760 | $-460 | $-2,861 | $-18,148 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 23,612 | 10,577 | N/A | -14,500 |
| PPE Investments | -818 | -1,478 | -222 | -688 | -181 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -19,000 |
| Sale Of Investment | N/A | N/A | N/A | N/A | -161 |
| Investing Cash Flow | $-818 | $22,134 | $10,355 | $-688 | $-33,842 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,945 | 9,872 | 5,650 | N/A | N/A |
| Common Stock Issued | 21,417 | 332 | 1,348 | N/A | 66,459 |
| Other Financing Activity | 15,545 | 0 | 0 | 0 | 13 |
| Financing Cash Flow | $41,907 | $10,204 | $6,998 | $N/A | $66,472 |
| Beginning Cash Position | 36,816 | 25,238 | 8,345 | 11,894 | 2,176 |
| End Cash Position | 71,460 | 36,816 | 25,238 | 8,345 | 16,658 |
| Net Cash Flow | $34,644 | $11,578 | $16,893 | $-3,549 | $14,482 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,445 | -20,760 | -460 | -2,861 | -18,148 |
| Capital Expenditure | -818 | -1,478 | -251 | -688 | -181 |
| Free Cash Flow | -7,263 | -22,238 | -711 | -3,549 | -18,329 |